Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Oct 27;4(10):228-33.
doi: 10.4240/wjgs.v4.i10.228.

Is lymphatic status related to regression of inflammation in Crohn's disease?

Affiliations

Is lymphatic status related to regression of inflammation in Crohn's disease?

Francesco Tonelli et al. World J Gastrointest Surg. .

Abstract

Aim: To investigate the status of the lymphatic vessels in the small bowel affected by Crohn's disease (CD) at the moment of surgery.

Methods: During the period January 2011-June 2011, 25 consecutive patients affected by CD were operated on in our Institution. During surgery, Patent Blue V was injected subserosally and the way it spread along the subserosa of the intestinal wall, through the mesenterial layers towards the main lymphatic collectors and eventually to the lymph nodes was observed and recorded. Since some patients had been undergone strictureplasty at previous surgery, we also examined the status of intestinal lymph vessels after previous strictureplasties. The same procedure was performed in a control group of 5 patients affected by colorectal cancer. Length of lesions, caliber, maximal thickness of the diseased intestinal wall, thickness of the wall at injection site and thickness of the mesentery were evaluated at surgery.

Results: We observed three features after the injection of Patent Blue V in the intestinal loops: (1) Macroscopically healthy terminal ileum of patients with CD or colon cancer showed thin lymphatic vessels linearly directed toward the mesentery; (2) In mild lesions in which the intestinal wall did not reach 8 mm of thickness, we observed short, wide and tortuous lymphatic vessels directed longitudinally along the intestinal axis toward disease-free areas and then transversally toward the mesentery; and (3) Injection in the severely affected lesions, that had a thickness of the intestinal wall over 10 mm, did not show any feature of lymphatic vessels at least on the subserosal surface. There was a correlation between the thickness of the parietal wall and the severity of the lymphatic alterations. Normal lymphatic vessels were observed at previous strictureplasties in the presence of complete regression of the inflammation.

Conclusion: Injection of Patent Blue V in the intestinal wall could help distinguish healthy tracts of the small bowel from those macroscopically borderline.

Keywords: Crohn’s disease; Inlflammation; Intestinal wall; Lymphatic vessels; Mesentery; Patent blue V; Strictureplasty; Surgery; Thickness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Healthy small bowel. A: the Patent Blue injected into the subserosal layer outlines a lymphatic vessel which rectilinearly goes into the mesenterium towards the lymph-node (arrow). Lymphatic vessels longitudinally directed are not observed; B: Small bowel affected by Crohn’s disease: the Patent Blue injected at the level of a skip lesion outlines a lymphatic vessel longitudinally directed in the small bowel wall and only from this site can it spread into the mesenterium.
Figure 2
Figure 2
Small bowel affected by Crohn’s disease. The Patent Blue injected into the subserosal layer soon leads to a high pressure spillage from the site of injection which highlights the absence of lymphatic drainage pathways (arrow).
Figure 3
Figure 3
Intestinal tracts previously treated by Heineke-Mikulicz strictureplasty, that do not appear macroscopically affected by recurrence of Crohn’s disease. The injection of Patent Blue soon highlights a lymphatic vessel which rectilinearly goes into the mesenterium towards the lymph node (arrows).
Figure 4
Figure 4
Previously performed side-to-side isoperistaltic strictureplasty. A: The lymph vessels appear straight and thin and easily reach the mesentery and the lymphnodes (arrows); B: Once the side-to-side isoperistaltic strictureplasty was resected, Crohn’s disease remission was visible at the internal site of dye injection, by the normal aspect of the mucosa.
Figure 5
Figure 5
Intestinal tract previously treated by Heineke-Mikulicz strictureplasty, that appears macroscopically affected by recurrence of stenosis in Crohn’s disease. A: the injection of Patent Blue quickly highlights a lymphatic vessel which rectilinearly goes towards the mesenterium; B: However, the vessel is cut off before entering into the mesenterium; in the meantime a lymphatic vessel that runs tangential to the wall of the ileum is drawn (arrow).

References

    1. Van Kruiningen HJ, Colombel JF. The forgotten role of lymphangitis in Crohn’s disease. Gut. 2008;57:1–4. - PubMed
    1. Blackburn G, Hadfield G, Hunt AH. Regional ileitis. St Bart's Hosp Rep. 1939;72:181–224.
    1. Warren S, Sommers SC. Cicatrizing enteritis as a pathologic entity; analysis of 120 cases. Am J Pathol. 1948;24:475–501. - PMC - PubMed
    1. Van Patter WN. Pathology and pathogenesis of regional enteritis (Dissertation). Minneapolis, Minn. University of Minnesota; 1952.
    1. Kalima TV. Experimental lymphatic obstruction in the ileum. Ann Chir Gynaecol Fenn. 1970;59:187–201. - PubMed